Data / Drug companies / Benzodiazepine
Benzodiazepine drugs: 28 drugs from 133 companies in the FDA NDC directory
Benzodiazepine is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 873 products in this class from 133 companies, covering 28 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 133Companies
- 873Products
- 28Drugs by generic name
Drugs in the Benzodiazepine class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Diazepam | 125 | 51 |
| Lorazepam | 146 | 38 |
| Alprazolam | 138 | 37 |
| Clonazepam | 145 | 36 |
| Temazepam | 87 | 28 |
| Midazolam hydrochloride | 43 | 19 |
| Clobazam | 36 | 18 |
| Chlordiazepoxide hydrochloride | 28 | 13 |
| Chlordiazepoxide hydrochloride and clidinium bromide | 15 | 13 |
| Triazolam | 14 | 9 |
| Clorazepate dipotassium | 25 | 8 |
| Midazolam | 25 | 6 |
| Oxazepam | 16 | 6 |
| Estazolam | 6 | 3 |
| Midazolam in sodium chloride | 5 | 3 |
| Chlordiazepoxide hcl and clidinium bromide | 2 | 2 |
| Diazepam oral | 2 | 2 |
| Alprazolam c-iv | 2 | 1 |
| Chlordiazepoxide and amitriptyline hydrochloride | 2 | 1 |
| Flurazepam hydrochloride | 2 | 1 |
| Midazolam in 0.8% sodium chloride | 2 | 1 |
| Alprazolam odt c-iv | 1 | 1 |
| Chlordiazepoxide hydrochloride, clidinium bromide | 1 | 1 |
| Diazepam intensol | 1 | 1 |
| Diazepam oral solution (concentrate) | 1 | 1 |
| Midazolam injection, 10 mg | 1 | 1 |
| Quazepam | 1 | 1 |
| Temazepam civ | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 42 | tablet; capsule | Generic drugs (ANDA) | May 16, 2023 |
| Remedyrepack Inc. | 36 | tablet; capsule | Generic drugs (ANDA) | July 19, 2026 |
| Aphena Pharma Solutions - Tennessee, LLC | 35 | tablet; capsule | Generic drugs (ANDA) | December 19, 2023 |
| Hikma Pharmaceuticals USA Inc. | 30 | injection; injection, solution | Generic drugs (ANDA) | July 8, 2026 |
| NuCare Pharmaceuticals,Inc. | 29 | tablet; capsule | Generic drugs (ANDA) | December 14, 2023 |
| A-S Medication Solutions | 23 | tablet; injection, solution | Generic drugs (ANDA) | May 16, 2023 |
| Asclemed USA, Inc. | 22 | tablet; tablet, extended release | Generic drugs (ANDA) | December 14, 2023 |
| Bryant Ranch Prepack | 22 | capsule; tablet | Generic drugs (ANDA) | April 27, 2021 |
| Clinical Solutions Wholesale, LLC | 21 | tablet; capsule | Generic drugs (ANDA) | June 25, 2023 |
| Chartwell RX, LLC | 19 | tablet; capsule | Generic drugs (ANDA) | October 20, 2020 |
| Advanced Rx of Tennessee, LLC | 17 | tablet; capsule | Generic drugs (ANDA) | April 14, 2025 |
| PD-Rx Pharmaceuticals, Inc. | 17 | tablet; capsule | Generic drugs (ANDA) | October 26, 2023 |
| Preferred Pharmaceuticals Inc. | 17 | tablet; capsule | Generic drugs (ANDA) | October 6, 2026 |
| Coupler LLC | 16 | tablet; capsule | Generic drugs (ANDA) | June 22, 2026 |
| Proficient Rx LP | 14 | tablet; tablet, extended release | Generic drugs (ANDA) | June 7, 2011 |
| Actavis Pharma, Inc. | 13 | tablet; tablet, orally disintegrating | Generic drugs (ANDA) | March 17, 2010 |
| American Health Packaging | 12 | tablet; capsule | Generic drugs (ANDA) | September 14, 2025 |
| Alembic Pharmaceuticals Inc. | 11 | tablet, orally disintegrating; capsule | Generic drugs (ANDA) | April 25, 2024 |
| Alembic Pharmaceuticals Limited | 11 | tablet, orally disintegrating; capsule | Generic drugs (ANDA) | April 25, 2024 |
| Bryant Ranch Prepack | 11 | capsule; tablet | Generic drugs (ANDA) | October 1, 2022 |
| Teva Pharmaceuticals USA, Inc. | 11 | tablet; tablet, orally disintegrating | Generic drugs (ANDA) | March 2, 2022 |
| Hospira, Inc. | 10 | injection, solution | Generic drugs (ANDA) | January 27, 2025 |
| Mylan Pharmaceuticals Inc. | 10 | tablet; tablet, extended release | Authorized generics (NDA) | January 17, 2003 |
| Proficient Rx LP | 10 | tablet; capsule | Generic drugs (ANDA) | October 11, 2021 |
| Advagen Pharma Ltd | 9 | tablet, orally disintegrating; tablet | Generic drugs (ANDA) | June 12, 2026 |
| Amneal Pharmaceuticals LLC | 9 | capsule; tablet, extended release | Generic drugs (ANDA) | May 23, 2016 |
| Ani Pharmaceuticals, Inc. | 9 | tablet | Generic drugs (ANDA) | December 16, 2022 |
| Ascend Laboratories, LLC | 9 | capsule; tablet | Generic drugs (ANDA) | October 18, 2023 |
| Aurolife Pharma, LLC | 9 | tablet | Generic drugs (ANDA) | September 23, 2023 |
| Direct_Rx | 9 | tablet; tablet, orally disintegrating | Generic drugs (ANDA) | August 22, 2025 |
| Par Health USA, LLC | 9 | tablet, orally disintegrating | Generic drugs (ANDA) | January 9, 2009 |
| Unit Dose Solutions, Inc. | 9 | tablet; capsule | Generic drugs (ANDA) | September 24, 2026 |
| Aurobindo Pharma Limited | 8 | tablet; capsule | Generic drugs (ANDA) | December 14, 2023 |
| Aurobindo Pharma Limited | 8 | tablet; tablet, extended release | Generic drugs (ANDA) | July 31, 2015 |
| AvPAK | 8 | tablet; capsule | Generic drugs (ANDA) | September 25, 2025 |
| Epic Pharma, LLC | 8 | capsule, gelatin coated; capsule | Generic drugs (ANDA) | November 9, 2021 |
| Henry Schein, Inc. | 8 | injection; injection, solution | Generic drugs (ANDA) | March 24, 2026 |
| PD-Rx Pharmaceuticals, Inc. | 8 | tablet; capsule | Generic drugs (ANDA) | January 19, 2018 |
| SpecGx LLC | 8 | capsule | New drug applications (NDA) | February 23, 2010 |
| Golden State Medical Supply, Inc. | 7 | tablet; capsule | Generic drugs (ANDA) | November 23, 2018 |
| Natco Pharma USA LLC | 7 | tablet; injection, solution | Generic drugs (ANDA) | July 28, 2023 |
| Onesource Specialty Pharma Limited | 7 | injection, solution | Generic drugs (ANDA) | February 27, 2026 |
| Solco Healthcare US, LLC | 7 | capsule; tablet | Generic drugs (ANDA) | January 5, 2023 |
| Leading Pharma, LLC | 6 | tablet; capsule | Generic drugs (ANDA) | July 9, 2025 |
| NorthStar RxLLC | 6 | tablet | Generic drugs (ANDA) | October 24, 2022 |
| Proficient Rx LP | 6 | tablet | Generic drugs (ANDA) | December 14, 2023 |
| Viatris Specialty LLC | 6 | tablet; tablet, extended release | New drug applications (NDA) | October 29, 2025 |
| Aphena Pharma Solutions - Tennessee, LLC | 5 | tablet; capsule | Authorized generics (NDA) | September 18, 1996 |
| Civica, Inc. | 5 | injection; injection, solution | Generic drugs (ANDA) | September 9, 2026 |
| Fresenius Kabi USA, LLC | 5 | injection, solution | Generic drugs (ANDA) | November 10, 2022 |
| Hikma Pharmaceuticals USA Inc. | 5 | solution, concentrate; solution | Generic drugs (ANDA) | April 30, 2002 |
| Micro Labs Limited | 5 | injection, solution; tablet | Generic drugs (ANDA) | January 1, 2024 |
| Mylan Institutional Inc. | 5 | tablet; capsule | Generic drugs (ANDA) | June 1, 2022 |
| Mylan Pharmaceuticals Inc. | 5 | tablet; tablet, film coated | Generic drugs (ANDA) | December 10, 1986 |
| Safecor Health, LLC | 5 | tablet; capsule | Generic drugs (ANDA) | March 30, 2026 |
| Zydus Pharmaceuticals USA Inc. | 5 | gel; tablet | Generic drugs (ANDA) | December 15, 2025 |
| Almatica Pharma LLC | 4 | capsule, extended release | New drug applications (NDA) | March 1, 2022 |
| Aphena Pharma Solutions - Tennessee, LLC | 4 | capsule; tablet | Generic drugs (ANDA) | April 21, 1987 |
| Asclemed USA Inc. | 4 | tablet | Generic drugs (ANDA) | July 31, 2015 |
| Bausch Health US LLC | 4 | tablet; capsule | New drug applications (NDA) | May 1, 2013 |
| Cardinal Health 107, LLC | 4 | tablet; injection, solution | Generic drugs (ANDA) | September 1, 2023 |
| Gland Pharma Limited | 4 | injection, solution | Generic drugs (ANDA) | August 12, 2024 |
| Neurelis, Inc | 4 | spray | New drug applications (NDA) | January 10, 2020 |
| PD-Rx Pharmaceuticals, Inc. | 4 | tablet; capsule | Generic drugs (ANDA) | March 25, 1998 |
| Precision Dose, Inc. | 4 | syrup; suspension | Generic drugs (ANDA) | March 10, 2025 |
| Sagent Pharmaceuticals | 4 | injection, solution | Generic drugs (ANDA) | February 15, 2026 |
| Sandoz Inc | 4 | tablet | Generic drugs (ANDA) | March 25, 1998 |
| St. Mary's Medical Park Pharmacy | 4 | tablet | Generic drugs (ANDA) | July 7, 2026 |
| Sun Pharmaceutical Industries, Inc. | 4 | tablet; suspension | Generic drugs (ANDA) | June 30, 2021 |
| Sunrise Pharmaceutical, Inc. | 4 | tablet; capsule | Generic drugs (ANDA) | December 9, 2024 |
| TruPharma, LLC | 4 | capsule; tablet | Generic drugs (ANDA) | September 1, 2026 |
| Unichem Pharmaceuticals (USA), Inc. | 4 | tablet | Generic drugs (ANDA) | November 2, 2026 |
| Accord Healthcare Inc. | 3 | tablet | Generic drugs (ANDA) | June 3, 2011 |
| American Health Packaging | 3 | capsule, gelatin coated | Generic drugs (ANDA) | December 17, 2007 |
| Amneal Pharmaceuticals NY LLC | 3 | tablet; suspension | Generic drugs (ANDA) | October 22, 2018 |
| Ani Pharmaceuticals, Inc. | 3 | tablet | Generic drugs (ANDA) | December 1, 2024 |
| Apotex Corp. | 3 | tablet | Generic drugs (ANDA) | September 22, 2022 |
| Aquestive Therapeutics | 3 | film | New drug applications (NDA) | November 1, 2018 |
| Camber Pharmaceuticals, Inc. | 3 | tablet; suspension | Generic drugs (ANDA) | February 24, 2020 |
| Direct RX | 3 | tablet | Generic drugs (ANDA) | November 18, 2019 |
| Fresenius Kabi USA, LLC | 3 | injection; injection, solution | Generic drugs (ANDA) | January 15, 2025 |
| H2-Pharma, LLC | 3 | tablet | New drug applications (NDA) | June 2, 1975 |
| Lundbeck Pharmaceuticals LLC | 3 | tablet; suspension | New drug applications (NDA) | December 10, 2013 |
| Major Pharmaceuticals | 3 | tablet; capsule | Generic drugs (ANDA) | August 23, 2022 |
| Navinta LLC | 3 | gel | Generic drugs (ANDA) | February 6, 2026 |
| NorthStar Rx LLC | 3 | tablet; suspension | Generic drugs (ANDA) | May 1, 2020 |
| Oceanside Pharmaceuticals | 3 | gel | Authorized generics (NDA) | July 29, 1997 |
| Redpharm Drug | 3 | tablet | Generic drugs (ANDA) | December 9, 2021 |
| Rising Pharma Holdings, Inc. | 3 | tablet | Generic drugs (ANDA) | July 24, 2025 |
| Somerset Therapeutics, LLC | 3 | injection, solution | Generic drugs (ANDA) | December 5, 2023 |
| Sun Pharmaceutical Industries, Inc. | 3 | tablet | Generic drugs (ANDA) | June 25, 2023 |
| Teva Pharmaceuticals USA, Inc. | 3 | capsule | Generic drugs (ANDA) | September 30, 1990 |
| Teva Pharmaceuticals USA, Inc. | 3 | tablet | Generic drugs (ANDA) | December 10, 1986 |
| Waylis Therapeutics LLC | 3 | tablet | New drug applications (NDA) | April 4, 2022 |
| Actavis Pharma, Inc. | 2 | tablet | Generic drugs (ANDA) | October 1, 1997 |
| American Health Packaging | 2 | liquid | Generic drugs (ANDA) | May 1, 2026 |
| Amneal Pharmaceuticals of New York LLC | 2 | capsule | Generic drugs (ANDA) | February 19, 2024 |
| B. Braun Medical Inc. | 2 | injection, solution | Generic drugs (ANDA) | October 15, 2025 |
| Baxter Healthcare Corporation | 2 | injection, solution | Generic drugs (ANDA) | July 28, 2026 |
| Dr. Reddy's Laboratories Inc. | 2 | tablet | Generic drugs (ANDA) | February 15, 2024 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 491 | 56.2% |
| Capsule | 141 | 16.2% |
| Injection, solution | 70 | 8% |
| Injection | 44 | 5% |
| Tablet, orally disintegrating | 34 | 3.9% |
| Tablet, extended release | 24 | 2.7% |
| Capsule, gelatin coated | 11 | 1.3% |
| Suspension | 11 | 1.3% |
| Gel | 11 | 1.3% |
| Solution | 7 | 0.8% |
| Syrup | 6 | 0.7% |
| Spray | 5 | 0.6% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.